This study is looking at care and outcomes for people with bipolarity I or II With a Major Depressive Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Alto Neuroscience
Condition: Bipolarity, Depression

View study

RecruitingNCT07553637

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 75 Years

Countries: United States, United Kingdom
Sponsor: Alto Neuroscience
Condition: Depression

View study

RecruitingNCT06030154

Amplification of Positivity for Alcohol Use

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Addiction, Depression, ...BehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Laureate Institute for Brain Research, Inc.
Condition: Addiction, Depression, ...

View study

RecruitingNCT05699226

Amplitude Titration to Improve ECT Clinical Outcomes

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralOver 50 Years

Countries: United States
Sponsor: University of New Mexico
Condition: Depression

View study

RecruitingNCT05065450

Amygdala Memory Enhancement

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDeviceFrom 18 Years to 75 Years

Countries: United States
Sponsor: Washington University School of Medicine
Condition: PTSD

View study

RecruitingNCT05703256

Amygdala Neurofeedback for Depression - Large Scale study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDeviceFrom 18 Years to 55 Years

Countries: United States
Sponsor: Kymberly Young
Condition: Depression

View study

RecruitingNCT07092345

An Adaptive Intervention to Increase Engagement to Community-Based Care After an ED Admission

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralFrom 8 Years to 17 Years

Countries: United States
Sponsor: Rhode Island Hospital
Condition: Suicidality

View study

RecruitingNCT03094429

Safety study of safety and Efficacy of NaBen®, in schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: SyneuRx International (Taiwan) Corp
Condition: Schizophrenia

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.